1Jaffe ES, Harris NL, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol, 1999,111 ( 1 Suppl1) : S8-12.
2McCarthy KP, Sloane JP, Weidemann LM. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J Clin Pathol, 1990, 43:429-432.
3Taylor JM, Spangnolo DV, Kay PH. B-cell target DNA quantity is a critical factor in the interpretation of B-cell clonality by PCR.Pathology, 1997,29:309-312.
4Gonzalez M, Gonzalez D, Lopez-Perez R, et al. Heteroduplex analysis of VDJ amplified segments from rearranged lgH genes for clonality assessments in B-cell non-Hodgkin "s lymphoma. A comparison between different strategies. Haematologica, 1999,84 : 779-784.
5Tbakhi A, Totos G, Pettay JD, et al. The effect of fixaton on detection of B-cell clonality by polymerase chain reaction. Mod Pathol, 1999,12:272-278.
6Essop MF, Blakolmer K, Close PM, et al. Analysis of low and high grade B-cell lymphoma subtypes using semi-nested PCR and two primer sets. Eur J Haematol, 1997, 59: 136-141.
7Macintyre EA, Delabesse E. Molecular approaches to the diagnosis and evaluation of lymphoid malignancies. Semi Hematol, 1999,36:373-389.
8Wu G, Greiner TC, Chang WC. Obtaining clone-specific primer and probe for the immunoglobulin heavy-chain gene from paraffinembedded tissue of B-cell lymphoma: technical considerations.Diagn Mol Pathol, 1997, 6: 147-153.
9Trainor KJ, Brisco M J, Wan JH, et al. Gene rearrangement in Band T-lymphoproliferative disease detected by the polymerase chain reaction. Blood, 1991,78 : 192-196.
10Hoeve MA, Krol AD, Philippo K, et al . Limitations of clonality analysis of B cell proliferations using CDR3 polymerase chain reaction. Mol Patho1,2000,53 : 194-200.
10Van Dongen J J, Langerak AW, Briiggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations; report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia, 2003,17(12) :2257-2317.
